A comparative analysis of the efficacy and safety of therapeutic interventions in phlegmasia cerulea dolens

Phlebology. 2021 Jun;36(5):392-400. doi: 10.1177/0268355520975581. Epub 2020 Nov 25.

Abstract

Objective: Present an institution's experience in management of phlegmasia cerulea dolens (PCD) with a review of the literature.

Methods: Beaumont Health's electronic record database was queried between July 2009 and November 2019 for inpatients with PCD. A comprehensive chart review was performed to verify the accuracy of the diagnosis and extract relevant parameters. Medians and proportions are reported.

Results: 22 patients met the criteria for PCD. 59% females. Median age 65 years (interquartile range [IQR] 22). Obesity was present in 45% of patients. 18 patients underwent either a single modality (55.5%) or a multimodality therapeutic approach (44.5%). Limb amputation was required in a third of patients who underwent catheter-directed thrombolysis or percutaneous thrombectomy alone. Death was highest after percutaneous thrombectomy alone (66%) followed by pharmacomechanical catheter-directed thrombolysis alone (50%).

Conclusion: Percutaneous interventions have become the mainstay in management of PCD as demonstrated in this large retrospective analysis and supported by literature review.

Keywords: Phlegmasia cerulea dolens; catheter-directed therapies; critical limb ischemia; endovascular interventions; thrombectomy.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Thrombectomy
  • Thrombolytic Therapy
  • Thrombophlebitis* / therapy
  • Venous Thrombosis*